CN, C., KM, T., L, V., KC, H., A, J., AB, S., . . . E, M. (2013). CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug products. The AAPS journal, 15(3), 623. https://doi.org/10.1208/s12248-013-9466-6
Chicago Style (17th ed.) CitationCN, Cruz, et al. "CDER Risk Assessment Exercise to Evaluate Potential Risks from the Use of Nanomaterials in Drug Products." The AAPS Journal 15, no. 3 (2013): 623. https://doi.org/10.1208/s12248-013-9466-6.
MLA (9th ed.) CitationCN, Cruz, et al. "CDER Risk Assessment Exercise to Evaluate Potential Risks from the Use of Nanomaterials in Drug Products." The AAPS Journal, vol. 15, no. 3, 2013, p. 623, https://doi.org/10.1208/s12248-013-9466-6.
Warning: These citations may not always be 100% accurate.